Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy

References

• La Rosee P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
   PubMed Web of Science ®Google Scholar
• Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–2914.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Park SS, Jeon YW, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104(2):269–276.
   PubMed Web of Science ®Google Scholar
• Cohen LA, Gutierrez L, Weiss A, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010;116(9):1574–1584.
   PubMed Web of Science ®Google Scholar
• Madkaikar M, Shabrish S, Desai M. Current updates on classification, diagnosis and treatment of hemophagocytic lymphohistiocytosis (HLH). Indian J Pediatr. 2016; 83(5):434–443.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou J, Shen DT, et al. Development and validation of the prognostic value of ferritin in adult patients with hemophagocytic lymphohistiocytosis. Orphanet J Rare Dis. 2020;15(1):71.
   PubMed Web of Science ®Google Scholar
• Zhao W, Tian W. Phagocytic syndrome China expert alliance, et al. Chinese expert consensus on the diagnosis and treatment of hemophagocytic syndrome. Chinese Medical Journal. 2018;98(02):91–95.
   Google Scholar
• Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49.
   PubMed Web of Science ®Google Scholar
• Knovich MA, Storey JA, Coffman LG, et al. Ferritin for the clinician. Blood Rev. 2009; 23(3):95–104.
   PubMed Web of Science ®Google Scholar
• Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800(8):760–769.
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Hock KG, Riley SB, et al. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol. 2017;96(10):1667–1672.
   PubMed Web of Science ®Google Scholar
• Schram AM, Campigotto F, Mullally A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125(10):1548–1552.
   PubMed Web of Science ®Google Scholar
• Sarangi R, Pathak M, Padhi S, et al. Ferritin in hemophagocytic lymphohistiocytosis (HLH): current concepts and controversies. Clin Chim Acta. 2020;510:408–415.
   PubMed Web of Science ®Google Scholar
• Lin TF, Ferlic-Stark LL, Allen CE, et al. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer. 2011;56(1):154–155.
   PubMed Web of Science ®Google Scholar
• Sandler RD, Tattersall RS, Schoemans H, et al. Diagnosis and management of secondary HLH/MAS following HSCT and CAR-t cell therapy in adults; a review of the literature and a survey of practice within EBMT centres on behalf of the autoimmune diseases working party (ADWP) and transplant complications working party (TCWP).Front Immunol. 2020;11:524.
   PubMed Web of Science ®Google Scholar
• Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015;168(1):63–68.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lu D, Ma S, et al. Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients. Hematology. 2019;24(1):606–612.
   PubMed Web of Science ®Google Scholar
• Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis. Blood. 2019;134(21):1783–1786.
   PubMed Web of Science ®Google Scholar
• Abou Shaar R, Eby CS, van Dorp S, et al. Increasing ferritin predicts early death in adult hemophagocytic lymphohistiocytosis. Int J Lab Hemato. 2021;43(5):1024-1031.
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90(3):220–224.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou J, Wu ZQ, et al. Ferritin index is a strong prognostic marker in adult hemophagocytic lymphohistiocytosis. Int J Clin Pract. 2021;75(3):e13704.
   PubMed Web of Science ®Google Scholar
• Posas-Mendoza TF, McLeod C, Davis W, et al. Etiologies and management of haemophagocytic lymphohistiocytosis: is it time for an updated protocol and targeted treatments? Rheumatology (Oxford)). 2021;60(6):2927–2933.
   PubMed Web of Science ®Google Scholar
• Bin Q, Gao JH, Luo JM. Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases. Ann Hematol. 2016;95(9):1411–1418.
   PubMed Web of Science ®Google Scholar